학술논문

Onboarding of siponimod in secondary progressive multiple sclerosis patients in Australia: Novel, real-world evidence from the MSGo digital support programme.
Document Type
Article
Source
Multiple Sclerosis Journal - Experimental, Translational & Clinical; Jan-Mar2024, Vol. 10 Issue 1, p1-11, 11p
Subject
MULTIPLE sclerosis
MEDICAL care
REGRESSION analysis
COVID-19 pandemic
DIGITAL technology
Language
ISSN
20552173
Abstract
Copyright of Multiple Sclerosis Journal - Experimental, Translational & Clinical is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)